Anteo Diagnostics Key People
Jack Hamilton career spans over 30 years in the energy sector. He has held senior positions across the energy sector over the past 15 years including heading up Australia’s largest resource project as Director North West Shelf Ventures for Woodside Energy Ltd., CEO for a Liquid Natural Gas project in PNG following on from a 21 year career with Shell in both local and international roles. His career gained experience across a range of functions including, strategy development, commercial marketing, mergers/acquisitions, capital raisings, manufacturing operations and project management in the energy and petrochemical sectors.
Jack is currently a non-executive director with Calix Ltd. as well as, on the advisory board for GHD Advisory, a division of GHD Engineering Ltd. He formerly held directorships with DUET Group Ltd, Southern Cross Electrical Engineering, Federation Training and chair of Renu Energy Ltd and Antilles Oil and Gas NL.
He graduated from Melbourne University with a degree in Bachelor of Chemical Engineering and a Doctorate of Philosophy in 1981 before joining Shell. Jack is married with two children and is resident in Melbourne, Victoria.
- Nomination and Remuneration Committee Member
- Audit and Risk Committee Member
- Managing Director and CEO (Jan 2009 – Jun 2016)
- Non-Executive Director (Jun 2016 – )
Dr Cumming has over 20 years experience in the healthcare and biotechnology market. Geoff’s roles have progressed from pure research to sales and marketing roles through to Managing Director level and Board seats. Previously Managing Director of Roche Diagnostic Systems – Oceania Regional Centre, where he transformed a loss making business to one achieving over 30% compound annual growth over a four year period and the highest profitability levels in Roche’s global organisation. Geoff was also Managing Director and CEO of an Australian based biotechnology company commercialising a range of products in cancer diagnosis and treatment. Dr Cumming is a Non-Executive Director of Medical Australia Limited (ASX: MLA) and Chairman of Sienna Cancer Diagnostics Limited (ASX:SDX).
- Non-Executive Director (Oct 2017 – )
Mr Sanderson joined the Anteo board as a Non-Executive Director in October 2017. He has been a director of private investment companies investing in public and private companies for the last 10 years. At Anteo, Matt’s objective is to provide focus on strategy and profitable execution and commercial growth of the technology. He is also strongly focused on providing shareholders with a clear and concise communication platform.
Christopher Parker’s career in the medical diagnostic and device industry spans more than 30 years. Having worked all over the world, he has developed substantial global experience of diverse healthcare environments and has a keen interest in emerging technologies. Beginning his career as a Medical Laboratory Scientist in Australia, Christopher then moved to the commercial sector in a business management role and spent almost 14 years working in the Australian in-vitro diagnostics industry. Christopher joined Roche Diagnostics in 1997 and over the next twenty years held roles of increasing scope and responsibility in sales, marketing, business development and country management across the Asia Pacific region (Singapore, Taiwan and India), in Canada and the United Kingdom. In 2017, Christopher retired from Roche Diagnostics, moved back to Australia and has since formed Stratigent Consulting, an organisation that specialises in providing customised, professional advice in the areas of Business Development, Change Management and People Leadership.
CFO and Company Secretary
Duncan Cornish B.Bus (Accty) ACA
- Chartered Accountant with significant experience as public company CFO and Secretary
- Focused on junior resource companies
- Financial, administration and governance
Mr Cornish is an accomplished and highly efficient corporate administrator and manager. Duncan has more than 20 years’ experience in the accountancy profession both in England and Australia, mainly with the accountancy firms Ernst & Young and PricewaterhouseCoopers. He has extensive experience in all aspects of company financial reporting, corporate regulatory and governance areas, business acquisition and disposal due diligence, capital raising and company listings and company secretarial responsibilities, and serves as corporate secretary and chief financial officer of several Australian and Canadian public companies. Mr. Cornish holds a Bachelor of Business (Accounting) and is a member of the Australian Institute of Chartered Accountants.